Agile Therapeutics, Inc. to appoint Jason Butch, the company's Vice President and Chief Accounting Officer, to serve as Principal Financial Officer, in addition to his current role as Principal Accounting Officer.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3548 USD | -0.92% | -4.60% | -81.81% |
15/05 | Agile Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
15/05 | Earnings Flash (AGRX) AGILE THERAPEUTICS Posts Q1 Revenue $5.7M | MT |
1st Jan change | Capi. | |
---|---|---|
-81.81% | 24.33L | |
+18.15% | 12TCr | |
+18.02% | 11TCr | |
+5.07% | 2.29TCr | |
-12.75% | 2.22TCr | |
-9.86% | 1.7TCr | |
-14.97% | 1.69TCr | |
-39.94% | 1.69TCr | |
+2.80% | 1.36TCr | |
+27.39% | 1.16TCr |
- Stock Market
- Equities
- AGRX Stock
- News Agile Therapeutics, Inc.
- Agile Therapeutics, Inc. to Appoint Jason Butch as Principal Financial Officer